Skip to main content
. Author manuscript; available in PMC: 2012 Sep 9.
Published in final edited form as: Naunyn Schmiedebergs Arch Pharmacol. 1993 May;347(5):521–526. doi: 10.1007/BF00166745

Fig. 3.

Fig. 3

Reversibility of the coronary flow (CBF) response to APEC infused at a rate giving a concentration in the coronary perfusate of 1 nM. The data are from one heart but are representative of the results in a second heart. The arrow indicates the end of APEC infusion and the dashed horizontal line the control coronary flow